Zahra Ismail

1.0k total citations · 1 hit paper
20 papers, 652 citations indexed

About

Zahra Ismail is a scholar working on Oncology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Zahra Ismail has authored 20 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Infectious Diseases and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Zahra Ismail's work include Cancer survivorship and care (5 papers), COVID-19 Clinical Research Studies (3 papers) and HIV-related health complications and treatments (3 papers). Zahra Ismail is often cited by papers focused on Cancer survivorship and care (5 papers), COVID-19 Clinical Research Studies (3 papers) and HIV-related health complications and treatments (3 papers). Zahra Ismail collaborates with scholars based in Canada, United States and United Kingdom. Zahra Ismail's co-authors include Muhammed Kermali, Amer Harky, Kiran Pillai, Adrienne K. Chan, Joep J. van Oosterhout, Alemayehu Amberbir, Colin Pfaff, Sumeet Sodhi, Theresa J. Allain and Lisa Barbera and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Life Sciences.

In The Last Decade

Zahra Ismail

17 papers receiving 631 citations

Hit Papers

The role of biomarkers in... 2020 2026 2022 2024 2020 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zahra Ismail Canada 8 428 171 136 96 65 20 652
Atul Sharma India 11 462 1.1× 248 1.5× 182 1.3× 49 0.5× 60 0.9× 23 853
Jiling Zhu China 10 462 1.1× 214 1.3× 225 1.7× 43 0.4× 62 1.0× 19 734
Luke Wooster United States 9 380 0.9× 209 1.2× 150 1.1× 27 0.3× 92 1.4× 14 1.1k
Zhaohui Tong China 8 295 0.7× 99 0.6× 72 0.5× 35 0.4× 90 1.4× 27 555
Xinsheng Yan China 3 723 1.7× 352 2.1× 217 1.6× 32 0.3× 135 2.1× 8 882
Raef Fadel United States 9 520 1.2× 298 1.7× 181 1.3× 25 0.3× 83 1.3× 36 707
Dayre McNally Canada 8 361 0.8× 170 1.0× 123 0.9× 63 0.7× 398 6.1× 21 975
Lianfeng Lu China 8 554 1.3× 260 1.5× 97 0.7× 20 0.2× 85 1.3× 21 758
Yunlei Deng China 8 554 1.3× 287 1.7× 216 1.6× 15 0.2× 127 2.0× 11 878

Countries citing papers authored by Zahra Ismail

Since Specialization
Citations

This map shows the geographic impact of Zahra Ismail's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zahra Ismail with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zahra Ismail more than expected).

Fields of papers citing papers by Zahra Ismail

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zahra Ismail. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zahra Ismail. The network helps show where Zahra Ismail may publish in the future.

Co-authorship network of co-authors of Zahra Ismail

This figure shows the co-authorship network connecting the top 25 collaborators of Zahra Ismail. A scholar is included among the top collaborators of Zahra Ismail based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zahra Ismail. Zahra Ismail is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ismail, Zahra, et al.. (2024). Advances in pharmacotherapy for heart failure and reduced ejection fraction: what’s new in 2024?. Expert Opinion on Pharmacotherapy. 25(14). 1887–1902.
2.
Ismail, Zahra, et al.. (2024). PRECOCIOUS PUBERTY: EPIDEMIOLOGY, CLINICAL PRESENTATION, DIAGNOSIS, AND ETIOLOGIES. International Journal of Advanced Research. 12(5). 49–53.
3.
Ismail, Zahra, et al.. (2024). Subacute Granulomatous Thyroiditis Occurring after SARS-CoV-2 Infection: A Case Report. Scholars Journal of Applied Medical Sciences. 12(4). 374–377.
4.
Ismail, Zahra, et al.. (2023). Impact of body mass index (BMI) and weight changes on hematopoietic stem cell transplant (HSCT) outcomes in the elderly population.. Journal of Clinical Oncology. 41(16_suppl). e19058–e19058. 1 indexed citations
5.
Kermali, Muhammed, et al.. (2020). The role of biomarkers in diagnosis of COVID-19 ?? A systematic review. 5 indexed citations
6.
Howell, Doris, Zahra Ismail, Susan J. Bartlett, et al.. (2020). Selecting, implementing and evaluating patient-reported outcome measures for routine clinical use in cancer: the Cancer Care Ontario approach. Journal of Patient-Reported Outcomes. 4(1). 101–101. 34 indexed citations
7.
Kermali, Muhammed, et al.. (2020). The role of biomarkers in diagnosis of COVID-19 – A systematic review. Life Sciences. 254. 117788–117788. 445 indexed citations breakdown →
8.
Amberbir, Alemayehu, Colin Pfaff, Zahra Ismail, et al.. (2019). Effect of cardio-metabolic risk factors on all-cause mortality among HIV patients on antiretroviral therapy in Malawi: A prospective cohort study. PLoS ONE. 14(1). e0210629–e0210629. 12 indexed citations
9.
Dai, Wei Fang, Jaclyn Beca, Helen Guo, et al.. (2019). Are population‐based patient‐reported outcomes associated with overall survival in patients with advanced pancreatic cancer?. Cancer Medicine. 9(1). 215–224. 13 indexed citations
10.
Amberbir, Alemayehu, et al.. (2018). Dyslipidemia among rural and urban HIV patients in south-east Malawi. PLoS ONE. 13(5). e0197728–e0197728. 19 indexed citations
11.
Ismail, Zahra, et al.. (2018). A tale of 2,000 charts: Measuring provider response to patient-reported outcome measures.. Journal of Clinical Oncology. 36(30_suppl). 157–157. 1 indexed citations
12.
Bartlett, Susan J., Michael Brundage, Denise Bryant‐Lukosius, et al.. (2018). Defining a patient-reported outcome measure (PROM) selection process: What criteria should be considered when choosing a PROM for routine symptom assessment in clinical practice?. Journal of Clinical Oncology. 36(30_suppl). 187–187. 3 indexed citations
13.
Ismail, Zahra, et al.. (2017). COST-EFFECTIVENESS IMPACTS CANCER CARE FUNDING DECISIONS IN BRITISH COLUMBIA, CANADA, EVIDENCE FROM 1998 TO 2008. International Journal of Technology Assessment in Health Care. 33(4). 481–486. 3 indexed citations
14.
Green, Esther, Martin Chasen, Michael Brundage, et al.. (2017). Oncology Nurses’ Attitudes Toward the Edmonton Symptom Assessment System: Results From a Large Cancer Care Ontario Study. Oncology nursing forum. 44(1). 116–125. 13 indexed citations
15.
Amberbir, Alemayehu, Zahra Ismail, Daniela Garone, et al.. (2016). The burden of hypertension, diabetes mellitus, and cardiovascular risk factors among adult Malawians in HIV care: consequences for integrated services. BMC Public Health. 16(1). 1243–1243. 83 indexed citations
17.
18.
Pataky, Reka, Zahra Ismail, Andrew J. Coldman, et al.. (2014). Cost-effectiveness of annual versus biennial screening mammography for women with high mammographic breast density. Journal of Medical Screening. 21(4). 180–188. 16 indexed citations
19.
20.
Ismail, Zahra, et al.. (2008). Emerging from the Shadows: Finding a Place for Children Born of War. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026